Jasper Therapeutics Inc.
(JSPR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Operating Expenses | 6,008 | 328 | 229 | 0 | 777 |
| Operating Income | -6,008 | -328 | -229 | N/A | -777 |
| Interest Expense | 111 | 0 | 0 | 0 | 0 |
| Other Income | -4,706 | -3,106 | 1,715 | 0 | 406 |
| Pre-tax Income | -10,825 | -3,433 | 1,487 | 0 | -371 |
| Income Tax | N/A | 1 | 58 | N/A | -48 |
| Net Income Continuous | -10,825 | -3,434 | 1,429 | N/A | -322 |
| Net Income | $-10,825 | $-3,434 | $1,429 | $N/A | $-322 |
| EPS Basic Total Ops | -61.40 | -13.70 | 5.70 | N/A | N/A |
| EPS Basic Continuous Ops | -61.40 | -13.74 | 5.72 | N/A | N/A |
| EPS Diluted Total Ops | -61.40 | -13.70 | 5.70 | N/A | N/A |
| EPS Diluted Continuous Ops | -61.40 | -13.74 | 5.72 | N/A | N/A |
| EBITDA(a) | $-6,008 | $-328 | $-229 | $N/A | $-777 |